Join the RSV Vaccine Pref3, Recombinant group to help and get support from people like you.
RSV Vaccine Pref3, Recombinant Support Group
Summary
Our support group for RSV Vaccine Pref3, Recombinant has 2 questions and 3 members. Updated 2 Feb 2024.
Latest questions
Further information
RSV Vaccine Pref3, Recombinant Patient information at Drugs.com
Latest news
FDA Approves Expanded Age Indication for GSK’s Arexvy, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk
Philadelphia, PA June 07 2024 – GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA)…
Ask a question
To post your own question to this support group, sign in or create an account.